Pace Medical (PMDL) Stock Price, News & Analysis

Company Overview

Pace Medical, Inc. designs and markets cardiac pacing products for medical professions in the United States and internationally. The company offers Model 4580 MICRO-PACE, a programmable and dual-chamber temporary cardiac pacemaker for multi-mode and multi-parameter operation; Model EV4543, a single-chamber temporary cardiac pacemaker that is designed to provide acute therapeutic, prophylactic, and diagnostic pacing support; and The Bedside Model 4170, a single-chamber temporary cardiac pacemaker. It also provides REF 4800 pacing analyzer, an internally powered and software-programmable device designed for continuous operation in the acute cardiac-care environment as temporary cardiac pacemaker and a pacing analyzer; and autoclavable and single-use surgical/patient extension cables and adapters. The company was founded in 1985 and is based in San Diego, California.

Key Stats

• Today's Range: $0.0020 to $0.0020
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.07
• Volume: N/A
• Average Volume: 21,153 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PMDL Stock Analysis - Frequently Asked Questions

How have PMDL shares performed this year?

Pace Medical's stock was trading at $0.0020 at the beginning of the year. Since then, PMDL stock has increased by 0.0% and is now trading at $0.0020.

How do I buy shares of Pace Medical?

Shares of PMDL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Electromedical Equipment
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:PMDL
• CIK: N/A
• Web: www.pacemedicalinc.com
• Phone: 858-452-2222
• Fax: 781-890-7914
• Employees: 12
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 7.23